Claforan and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claforan (cefotaxime sodium) and Cymbalta (duloxetine hydrochloride). Common drug interactions include bladder cyst among females and catheter site phlebitis among males.

The phase IV clinical study analyzes what interactions people have when they take Claforan and Cymbalta. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Claforan?

Claforan has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,527 Claforan users. Check the latest studies of Claforan.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.

On Jul, 15, 2026

19 people who take Claforan and Cymbalta together, and have interactions are studied.

Claforan and Cymbalta drug interactions.

What are the common drug interactions of Claforan and Cymbalta, by gender? *:

female:

Bladder cyst
Blood pressure increased
Bone disorder
Bone pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiomegaly (increased size of heart than normal)
Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
Constipation
Cough
Cystitis (inflammation of the wall of the bladder)

male:

Catheter site phlebitis (infection of veins at catheter site)
Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
Abasia (inability to walk)
Abdominal distension
Abdominal pain
Acute myocardial infarction (acute heart attack)
Acute sinusitis
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Affective disorder (mental disorder)
Anaemia (lack of blood)

What are the common drug interactions of Claforan and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Acute sinusitis
Affective disorder (mental disorder)
Anaemia (lack of blood)
Arthralgia (joint pain)
Bladder cyst
Blood pressure increased
Bone disorder
Bone pain
Cardiomegaly (increased size of heart than normal)
Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)

60+:

Catheter site phlebitis (infection of veins at catheter site)
Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)

What are the existing conditions these people have? *

Stress And Anxiety: 12 people, 63.16%
Pain: 12 people, 63.16%
Neoplasm Malignant (cancer tumour): 12 people, 63.16%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%
Hepatitis C: 1 person, 5.26%
Cardiomyopathy (weakening of the heart muscle): 1 person, 5.26%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Claforan and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously